Vaccine
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 3.4 | Q2 | 56.0% | 1.186 | Q1 | 87.8% |
| 2024 | 3.5 | Q2 | 65.6% | 1.248 | Q1 | 89.2% |
| 2023 | 4.5 | Q2 | 72.8% | 1.342 | Q1 | 91.2% |
| 2022 | 5.5 | Q2 | 79.7% | 1.493 | Q1 | 93.0% |
| 2021 | 4.2 | Q3 | 63.5% | 1.392 | Q1 | 92.2% |
| 2020 | — | — | 1.585 | Q1 | 93.1% | |
| 2019 | — | — | 1.683 | Q1 | 94.0% | |
| 2018 | — | — | 1.759 | Q1 | 93.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1873-2518
ISSN
0264-410X
country
GBcoverage
1983-2026